Your SlideShare is downloading. ×
Innovative Chlamydia Diagnostic Technologies and Emerging Markets
Innovative Chlamydia Diagnostic Technologies and Emerging Markets
Innovative Chlamydia Diagnostic Technologies and Emerging Markets
Innovative Chlamydia Diagnostic Technologies and Emerging Markets
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Innovative Chlamydia Diagnostic Technologies and Emerging Markets

106

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
106
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Innovative Chlamydia Diagnostic Technologies and EmergingMarketsReport Details:Published:November 2012No. of Pages: 184Price: Single User License – US$3850The report contains 184 pages, 15 tables and presents a detailed analysis of the Chlamydiadiagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Currentscientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The reportprovides the 5- and 10-year test volume and sales forecasts by country for the following marketsegments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales andmarket share estimates for major suppliers of Chlamydia tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies,Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrantsdeveloping innovative technologies and products; and identifies emerging business expansionopportunities, alternative market penetration strategies, market entry barriers and risks, andstrategic planning issues and concerns.Get your copy of this report @http://www.reportsnreports.com/reports/208659-innovative-chlamydia-diagnostic-technologies-and-emerging-markets.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. Chlamydia Worldwide Market and Technology OverviewA. Background0 Chlamydia Psittaci
  • 2. 0 Chlamydia Pneumoniae0 Chlamydia TrachomatisB. Diagnostic TestsC. Vaccines and DrugsD. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other SuppliersE. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherIII. France: Market Size, Growth and Major Suppliers’ Sales and Market SharesIV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market SharesV. Italy: Market Size, Growth and Major Suppliers’ Sales and Market SharesVI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market SharesVII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market SharesVIII. UK: Market Size, Growth and Major Suppliers’ Sales and Market SharesIX. USA: Market Size, Growth and Major Suppliers’ Sales and Market SharesX. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for DecentralizedTesting Markets1. Marketing Approaches2. Product Complexity
  • 3. 3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationXI. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesXII. Competitive AssessmentsAbbottAffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNanogen/ElitechNovartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenom
  • 4. SeraCareSiemensTakara BioThermo FisherWallacWakoList of TablesMajor Companies Developing or Marketing ChlamydiaTestsFranceChlamydia Test Volume and Diagnostics Sales Forecast by Market SegmentFranceChlamydia Diagnostics Sales by Major SupplierGermanyChlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentItalyChlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentJapanChlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentJapanChlamydia Diagnostics Sales by Major SupplierSpainChlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentSpainChlamydia Diagnostics Sales by Major SupplierU.K.Chlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentU.S.A.Chlamydia Test Volume and Diagnostics Sales Forecast By Market SegmentU.S.A.Chlamydia Diagnostics Sales by Major SupplierContact: sales@reportsandreports.com for more information.

×